Grace Therapeutics announces participation in BIO-Europe and Craig-Hallum conferences

GRCE•2026-11-05

Grace Therapeutics will attend BIO-Europe 2026 in Cologne on Nov. 9-11, and CEO Prashant Kohli will meet investors at the Craig-Hallum Alpha Select Conference in New York on Nov. 17.

1. Conference participation

Grace Therapeutics will attend BIO-Europe 2026 in Cologne, Germany, from Nov. 9-11. CEO Prashant Kohli will meet investors at the Craig-Hallum 17th Annual Alpha Select Conference in New York on Nov. 17.

Grace Therapeutics announces participation in BIO-Europe and Craig-Hallum conferences

1. Conference participation

Related News

Gilead target price raised to $200 from $165

Sezzle soars on annual forecast hike, Q3 profit beat

Globalstar Q3 revenue falls on lower service sales, posts net loss

CRA International Q3 revenue beats estimates on broad-based growth

Canada's Lightspeed Q2 revenue slightly beats estimates on platform adoption